Enovis Corporation Share Price

Equities

ENOV

US1940145022

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 21:00:02 16/07/2024 BST 5-day change 1st Jan Change
46.38 USD +3.67% Intraday chart for Enovis Corporation +6.01% -17.21%
Sales 2024 * 2.12B 163B Sales 2025 * 2.28B 175B Capitalization 2.54B 195B
Net income 2024 * -119M -9.13B Net income 2025 * 54M 4.14B EV / Sales 2024 * 1.75 x
Net Debt 2024 * 1.18B 90.17B Net Debt 2025 * 1.07B 81.95B EV / Sales 2025 * 1.59 x
P/E ratio 2024 *
-33.1 x
P/E ratio 2025 *
43.8 x
Employees 6,550
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.03%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.67%
1 week+6.01%
Current month+2.61%
1 month+3.43%
3 months-17.91%
6 months-20.27%
Current year-17.21%
More quotes
1 week
44.14
Extreme 44.14
46.62
1 month
43.30
Extreme 43.3
46.62
Current year
43.30
Extreme 43.3
65.03
1 year
43.04
Extreme 43.04
66.14
3 years
43.04
Extreme 43.04
164.01
5 years
36.69
Extreme 36.69
164.01
10 years
36.69
Extreme 36.69
210.18
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 23/07/15
Director of Finance/CFO 45 31/12/19
Director/Board Member 58 31/12/18
Members of the board TitleAgeSince
Director/Board Member 57 03/04/22
Director/Board Member 53 12/05/08
Director/Board Member 62 14/06/16
More insiders
Date Price Change Volume
16/07/24 46.38 +3.67% 1,252,899
15/07/24 44.74 -2.80% 742,099
12/07/24 46.03 +0.77% 573,320
11/07/24 45.68 +4.32% 502,895
10/07/24 43.79 +0.09% 384,679

Delayed Quote Nyse, July 16, 2024 at 09:00 pm

More quotes
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
46.38 USD
Average target price
72.1 USD
Spread / Average Target
+55.45%
Consensus